missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ BRMS1 Recombinant Rabbit Monoclonal Antibody (23GB3015), Invitrogen™

Rabbit Recombinant Monoclonal Antibody

Brand:  Invitrogen™ MA553313

 View more versions of this product

Product Code. 30088395

  • £179.00 / 20µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

This gene reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. The protein encoded by this gene localizes primarily to the nucleus and is a component of the mSin3a family of histone deacetylase complexes (HDAC). The protein contains two coiled-coil motifs and several imperfect leucine zipper motifs. Alternative splicing results in two transcript variants encoding different isoforms.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

BRMS1
Recombinant Monoclonal
Unconjugated
BRMS1
AV003220; AW554636; breast cancer metastasis suppressor 1; breast cancer metastasis-suppressor 1; Breast cancer metastasis-suppressor 1 homolog; BRMS 1; BRMS1
Rabbit
Affinity chromatography
RUO
25855
-20°C
Liquid
Flow Cytometry, Western Blot, Immunocytochemistry
23GB3015
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q9HCU9
BRMS1
A synthesized peptide derived from BRMS1 (1-56AA).
20 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.